← Evidence map

ArticleBMC cancer2013

Cost-effectiveness of MRI for breast cancer screening in BRCA1/2 mutation carriers.

Reka Pataky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

24 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23837641